Page last updated: 2024-09-04

atrasentan and pituitrin

atrasentan has been researched along with pituitrin in 5 studies

Compound Research Comparison

Studies
(atrasentan)
Trials
(atrasentan)
Recent Studies (post-2010)
(atrasentan)
Studies
(pituitrin)
Trials
(pituitrin)
Recent Studies (post-2010) (pituitrin)
3584110822,1375942,101

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boemke, W; Francis, RC; Höhne, C; Kaczmarczyk, G2
Boemke, W; Donaubauer, B; Francis, RC; Höhne, C; Kaisers, U; Klein, A1
Boemke, W; Francis, RC; Höhne, C; Kaisers, U; Klein, A; Pickerodt, P1
Boemke, W; Francis, RC; Höhne, C; Kaisers, UX; Klein, A; Pickerodt, PA1

Other Studies

5 other study(ies) available for atrasentan and pituitrin

ArticleYear
Haemodynamic and hormonal changes during haemorrhage in conscious dogs treated with an endothelin-A receptor antagonist.
    Clinical science (London, England : 1979), 2002, Volume: 103 Suppl 48

    Topics: Action Potentials; Acute Disease; Angiotensin II; Animals; Atrasentan; Blood Pressure; Cardiac Output; Dogs; Endothelin Receptor Antagonists; Endothelin-1; Hemorrhage; Norepinephrine; Pyrrolidines; Random Allocation; Receptor, Endothelin A; Vascular Resistance; Vasodilator Agents; Vasopressins

2002
Effect of angiotensin II and endothelin-1 receptor blockade on the haemodynamic and hormonal changes after acute blood loss and after retransfusion in conscious dogs.
    Acta physiologica Scandinavica, 2004, Volume: 180, Issue:4

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Atrasentan; Blood Pressure; Blood Transfusion; Cardiac Output; Dogs; Endothelin-1; Epinephrine; Female; Glomerular Filtration Rate; Hemodynamics; Hemorrhage; Losartan; Norepinephrine; Pyrrolidines; Receptor, Endothelin A; Stroke Volume; Urine; Vascular Resistance; Vasopressins

2004
Endothelin-a receptor blockade does not debilitate the cardiovascular and hormonal adaptation to xenon or isoflurane anesthesia in dogs.
    Experimental biology and medicine (Maywood, N.J.), 2006, Volume: 231, Issue:6

    Topics: Acclimatization; Anesthetics, Inhalation; Angiotensin II; Animals; Atrasentan; Cardiovascular Physiological Phenomena; Dogs; Endothelin A Receptor Antagonists; Epinephrine; Female; Isoflurane; Norepinephrine; Pyrrolidines; Vasopressins; Xenon

2006
ETA-receptor blockade impairs vasoconstriction after hemorrhage in xenon-anesthetized dogs treated with an AT1-receptor antagonist.
    Canadian journal of physiology and pharmacology, 2008, Volume: 86, Issue:6

    Topics: Anesthesia; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Atrasentan; Blood Pressure; Dogs; Endothelin A Receptor Antagonists; Endothelin-1; Female; Hemodynamics; Hemorrhage; Losartan; Pyrrolidines; Vascular Resistance; Vasoconstriction; Vasopressins; Xenon

2008
Endothelin receptor subtype A blockade does not affect the haemodynamic recovery from haemorrhage during xenon/remifentanil or isoflurane/remifentanil anaesthesia in dogs.
    Veterinary anaesthesia and analgesia, 2010, Volume: 37, Issue:3

    Topics: Anesthesia; Anesthesia, Inhalation; Anesthesia, Intravenous; Anesthetics, Inhalation; Anesthetics, Intravenous; Animals; Atrasentan; Blood Loss, Surgical; Catecholamines; Dog Diseases; Dogs; Endothelin A Receptor Antagonists; Endothelin-1; Epinephrine; Female; Hemodynamics; Hemorrhage; Isoflurane; Norepinephrine; Piperidines; Pyrrolidines; Remifentanil; Time Factors; Vascular Resistance; Vasopressins; Xenon

2010